SCHEMBL20156487

SCHEMBL20156487

CC1CCCCCC(Br)CC1

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.37
ACHE P22303 1/20 0.33
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23945125 1.00 EPHX1 (0.37) EPHX1ACHEKMT2A
SCHEMBL23945122 1.00 EPHX1 (0.37) EPHX1ACHEKMT2A
SCHEMBL22384120 0.94 ACHE (0.36) EPHX1ACHEKMT2A
SCHEMBL16318110 0.92 ACHE (0.34) EPHX1ACHEKMT2A
SCHEMBL20368999 0.92
SCHEMBL21971979 0.88 CYP2C9 (0.32) EPHX1ACHE
SCHEMBL18257312 0.85
SCHEMBL255290 0.85
SCHEMBL5479131 0.82
Methyl Alcohol SCHEMBL6620100 0.79 ESR2 (0.32) EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021535-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES MERCK SHARP & DOHME CORP. (US) 2021-02-04 WO disclosed
WO-2018089904-A1 HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS 3-V BIOSCIENCES, INC. (US) 2018-05-17 WO disclosed